Managing Pulmonary Hypertension
Pulmonary hypertension is a major concern for
patients admitted in ICUs for respiratory distress and cardiac ailments. The
management of pulmonary hypertension needs proper evaluation of the symptoms
together with the co-existing morbidities to support faster recovery and
prevent complications.
While patients with respiratory diseases like
pulmonary hypertension (PH) do not appear to be at a higher risk for
contracting COVID-19, they might be more likely to develop serious chest
infections due to the exposure to the virus.
Healthcare practitioners, hence, need to take extra
precautions to minimize the patient's risk of COVID-19. They also need to train
and educate patients and their families about the precautions they should take
in order to avoid complications related to pulmonary hypertension as well as
COVID-19.
Generally, it is advisable for patients to:
·
Stock up on all prescription
medications and supplies to last for a few weeks.
·
Stay at home as much as possible
·
Avoid visiting crowded places
·
Avoid non-essential travel
Those with existing respiratory issues should wear a
face mask only when necessary as it might make breathing more difficult for
them.
There are several treatments for pulmonary
hypertension including medications and surgeries. The patient may be advised
one or more medications depending on a number of factors, including the causes
of PH and the severity of symptoms.
Treatments usually include anticoagulant medicines
like warfarin to prevent blood clots, or diuretics to remove excess fluids from
the body. Digoxin can help to improve the symptoms by slowing down the heart
rate and strengthening the cardiac muscle contractions.
Critical care of patients with pulmonary
hypertension in ICU usually includes mechanical or non-mechanical ventilation
depending on the extent of breathing difficulties.
Other treatments recommended for PH include
endothelin receptor antagonists, phosphodiesterase 5 inhibitors,
prostaglandins, soluble guanylate cyclase stimulators, and calcium channel
blockers.
Some patients with PH may need surgery. For
example; pulmonary endarterectomy is aimed at removing abnormal blood clots in
the pulmonary arteries in patients having chronic thromboembolic pulmonary
hypertension.
Atrial septostomy and balloon pulmonary angioplasty
can also be performed in some patients when medications fail to produce the
desired results. Lung transplantation may be recommended only in severe cases.
You can learn more about the management of PH at
our ‘Critical Care Webinar’ being conducted on 6th November from 10 am to 3 pm.
We will discuss the various treatments and protocols for the management of PH
in the ICU settings as well as at home. You will also learn about how to train
patients to care for themselves after discharge.
The other topics discussed during this respiratory conference include sedation
and analgesia monitoring in ICU patients, and ventilator management of patients
with ARDS. We will also discuss the ICU protocols aimed at improving outcomes.
Our panel of expert physicians will share with you
some case studies of ICU patients to help you understand the topics with a
practical view.
Join the
webinar to keep yourself updated about critical care and
management to improve your skills and knowledge.